- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in sun pharmaceuticals
Delivering Growth
Sun Pharma showed tremendous resilience in the face of Covid by maintaining business continuity and recording revenue growth
Read MoreSun Pharma Recalls Products In US Market
The US arm of the domestic pharma major is recalling Tadalafil tablets in the American market, according to the latest enforcement report of the USFDA.
Read MoreSun Pharma Forays Into Nutrition Bar Segment With Launch Of Revital NXT
The market for nutrition bars in India is growing rapidly, with an increasing focus on fitness for a healthy lifestyle.
Read MoreSun Pharma Shares Zoom 10 %; M-Cap Jumps Rs 16,970.94 Cr After Earnings
Consolidated revenue from operations stood at Rs 9,718.74 crore for the quarter under consideration. It was Rs 7,585.25 crore for the same period a year ago
Read MoreNo Plans To Get Into Vaccine Production As It Requires Separate Manufacturing Infra: Sun Pharma
The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth.
Read MoreSun Pharma Acquires Rights To Trademarks Of 3 Diabetes Drug Brands In India From AstraZeneca
AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016, for distribution of Dapagliflozin.
Read MoreSun Pharma Q4 Net Profit Zooms Over Two-Fold To Rs 894.15 Cr
Shares of Sun Pharmaceutical Industries closed at Rs 699.75 per scrip on BSE, down 0.55 per cent from its previous close.
Read MoreSun Pharma Recalls 50,868 Bottles Of Diabetes Drug In US
The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to 'presence of foreign substance identified as activated carbon', as per the latest Enforcement Report issued by the US health regulator.
Read MoreSun Pharma Appoints Pawan Goenka, Rama Bijapurkar As Additional Independent Directors
Bijapurkar has an independent management consulting practice, works across sectors, and describes her domain as bringing market focus to business strategy.
Read MoreSun Pharma, Alembic Recall Products In The US Market
Princeton (New Jersey) based Sun Pharmaceutical Industries Inc is also recalling 2,520 bottles of diabetes drug, Metformin HCl Extended-Release tablets, in the US market.
Read MoreSun Pharma To Launch Complete Range Of Generic Anti-Epilepsy Drug
Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has fast onset of action and promising efficacy.
Read MoreSun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI
Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd.
Read MoreEquity Indices End Flat After Choppy Trade, Energy Stocks Lose
BSE S&P Sensex was down by 46 points or 0.13 per cent at 34,916 while the Nifty 50 edged lower by 10 points or 0.1 per cent at 10,302.
Read MoreSun Pharma Testing Plant-based Drug As Potential COVID-19 Treatment
The company said the trial will be conducted across 12 centers in India in 210 patients and a human safety study of the drug has been completed.
Read MoreSun Pharma Initiates Phase Two Clinical Trial On AQCH As Potential Treatment For COVID-19 Patients
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and India's top pharmaceutical company.
Read More